Evidence map›Paper›PMID 31076557›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Integrative analysis of gene expression, DNA methylation, physiological traits, and genetic variation in human skeletal muscle.

D Leland Taylor, Anne U Jackson, Narisu Narisu, Gibran Hemani, Michael R Erdos, Peter S Chines, Amy Swift, Jackie Idol, John P Didion, Ryan P Welch and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 3 pooled it
21.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 3 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Integrated Genomic and Transcriptomic Study RevealsCirculation. Genomic and precision medicine · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 4 countries.

D Leland TaylorMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.ORCID 0000-0001-6498-6970
Anne U JacksonDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109.
Narisu NarisuMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
Gibran HemaniMRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, BS8 2BN Bristol, United Kingdom.
Michael R ErdosMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
Peter S ChinesMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
Amy SwiftMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
Jackie IdolMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
John P DidionMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
Ryan P WelchDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109.
Leena KinnunenDepartment of Public Health Solutions, National Institute for Health and Welfare, FI-00271 Helsinki, Finland.
Jouko SaramiesRehabilitation Center, South Karelia Social and Health Care District EKSOTE, Fl-53130 Lappeenranta, Finland.
Timo A LakkaInstitute of Biomedicine, School of Medicine, University of Eastern Finland, Fl-70211 Kuopio, Finland.
Markku LaaksoInstitute of Clinical Medicine, Internal Medicine, University of Eastern Finland, FI-70210 Kuopio, Finland.
Jaakko TuomilehtoDepartment of Public Health Solutions, National Institute for Health and Welfare, FI-00271 Helsinki, Finland.
Stephen C J ParkerDepartment of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI 48109.
Heikki A KoistinenDepartment of Public Health Solutions, National Institute for Health and Welfare, FI-00271 Helsinki, Finland.
George Davey SmithMRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, BS8 2BN Bristol, United Kingdom.ORCID 0000-0002-1407-8314
Michael BoehnkeDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109.
Laura J ScottDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109; ljst@umich.edu birney@ebi.ac.uk collinsf@mail.nih.gov.
Ewan BirneyEuropean Molecular Biology Laboratory, European Bioinformatics Institute, CB10 1SD Hinxton, United Kingdom; ljst@umich.edu birney@ebi.ac.uk collinsf@mail.nih.gov.
Francis S CollinsMedical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892; ljst@umich.edu birney@ebi.ac.uk collinsf@mail.nih.gov.ORCID 0000-0002-1023-7410
National Institutes of Health · USUniversity of Michigan · USUniversity of Bristol · GBUniversity of Eastern Finland · FIUniversity of Helsinki · FIEtelä-Karjalan sosiaali ja terveyspiiri · FIEuropean Bioinformatics Institute · GBFinnish Institute for Health and Welfare · FI

Funding

Genetic analysis of type II diabetes in Finnish populationZIAHG000024 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ERDOS, MICHAEL · 2009 to 2025
$38.2M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Identifying Genes for Type 2 Diabetes: FUSIONU01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2009 to 2021
$11.6M
Identifying Genes for Type 2 Diabetes:FUSIONR01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2003 to 2025
$6.7M
GENETIC ANALYSIS OF TYPE II DIABETES IN FINNISH POPULATIONZ01HG000024 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI COLLINS, FRANCIS S. · 1995 to 2008
$6.2M
Context-specific and combinatorial genetic regulatory grammars in diabetesR01DK117960 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Stephen CJ Parker · 2018 to 2026
$2.8M
Synthesizing genome, epigenome, and transcriptome datasets in type 2 diabetes.R00DK099240 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PARKER, STEPHEN CJ · 2015 to 2017
$726k
Intramural NIH HHS Z01 HG000024Intramural NIH HHS ZIA HG000024Medical Research Council MC_UU_00011/1NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R00 DK099240NIDDK NIH HHS R01 DK062370NIDDK NIH HHS R01 DK117960NIDDK NIH HHS U01 DK062370Wellcome TrustWellcome Trust 208806/Z/17/Z
6 · The paper itself

Abstract

We integrate comeasured gene expression and DNA methylation (DNAme) in 265 human skeletal muscle biopsies from the FUSION study with >7 million genetic variants and eight physiological traits: height, waist, weight, waist-hip ratio, body mass index, fasting serum insulin, fasting plasma glucose, and type 2 diabetes. We find hundreds of genes and DNAme sites associated with fasting insulin, waist, and body mass index, as well as thousands of DNAme sites associated with gene expression (eQTM). We find that controlling for heterogeneity in tissue/muscle fiber type reduces the number of physiological trait associations, and that long-range eQTMs (>1 Mb) are reduced when controlling for tissue/muscle fiber type or latent factors. We map genetic regulators (quantitative trait loci; QTLs) of expression (eQTLs) and DNAme (mQTLs). Using Mendelian randomization (MR) and mediation techniques, we leverage these genetic maps to predict 213 causal relationships between expression and DNAme, approximately two-thirds of which predict methylation to causally influence expression. We use MR to integrate FUSION mQTLs, FUSION eQTLs, and GTEx eQTLs for 48 tissues with genetic associations for 534 diseases and quantitative traits. We identify hundreds of genes and thousands of DNAme sites that may drive the reported disease/quantitative trait genetic associations. We identify 300 gene expression MR associations that are present in both FUSION and GTEx skeletal muscle and that show stronger evidence of MR association in skeletal muscle than other tissues, which may partially reflect differences in power across tissues. As one example, we find that increased

Indexed as

Muscle, SkeletalBlood GlucoseBody Weights and MeasuresDiabetes Mellitus, Type 2DNA MethylationGene ExpressionGenome-Wide Association StudyGenomicsHumansInsulinQuantitative Trait LociBlood GlucoseInsulinDNA methylationeQTLgene expressionmQTLskeletal muscle

Identifiers

PMID31076557
PMCPMC6561151
OpenAlexW2944117578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.